relugolix

FDA Drug Profile — Orgovyx

Drug Details

Generic Name
relugolix
Brand Names
Orgovyx
Application Number
NDA214621
Sponsor
Sumitomo Pharma America, Inc.
NDC Codes
2
Dosage Forms
TABLET, FILM COATED, POWDER
Routes
ORAL
Active Ingredients
RELUGOLIX

Indications and Usage

1 INDICATIONS AND USAGE ORGOVYX is indicated for the treatment of adult patients with advanced prostate cancer. ORGOVYX is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of adult patients with advanced prostate cancer ( 1 ).